Markus Puhlmann serves as Executive at Perspective Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Markus Puhlmann has executed 4 insider transactions totaling $328.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 24, 2024 involved purchasing 280,000 shares valued at $140.0K.
Markus Puhlmann currently holds 1,375,425 shares of Perspective Therapeutics, Inc. (CATX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Markus Puhlmann has been a net buyer of CATX stock. They have purchased $328.2K and sold $0 worth of shares.
Markus Puhlmann's most recent insider trade was on Jan 24, 2024, when they purchased 280,000 shares at $0.50 per share.
Get notified when new Form 4 filings are submitted
| $0.34 |
| Discretionary |
| Dec 18, 2023 | CATX | $15.7K | Purchase | 60,419 | $0.26 | Discretionary |
| Dec 15, 2023 | CATX | $36.5K | Purchase | 135,006 | $0.27 | Discretionary |